Cream - 1%

Vaginal ovules - 150 mg

Ovules - ( 200 mg + 500 mg + 660.000 IU + 15 mg )

Meliora contains the active substances chloramphenicol, metronidazole, nystatin and hydrocortisone acetate.

Meliora is used to treat or to prevent the vaginal and of the cervix infections caused by certain microorganisms.

Indications:

• treatment of vaginitis and cervicitis caused by aerobic and anaerobic bacteria (including Clostridium spp), and by Gram-positive or Gram-negative organisms;
• treatment of vaginitis and cervicitis caused by Trichomonas vaginalis in combination with other types of microorganisms;
• treatment of vaginitis and cervicitis caused by Mycoplasma spp or Chlamydia spp in association with other microorganisms;
• treatment of mycotic vaginitis caused by Candida in combination with other types of microorganisms;
• treatment of mixed vaginitis caused by the association bacteria, Trichomonas vaginalis, Candida spp and Mycoplasma spp or Chlamydia spp;
• prevention of vaginitis and cervicitis for women undergoing with immunosuppressive therapy, chemotherapy or corticosteroids and for women undergoing radiotherapy;
• prevention of vaginitis and cervicitis in patients who will be subjected to exploratory or surgical intervention in the genital area (hysterosalpingography, tubal surgery, endometrial biopsy etc.);
• treatment of pathogenic flora before harvesting smear for PAP - test to clarify the microscopic field and to improve interpretation cytotest.

Meliora ovules are indicated to be used in the adult females. If necessary, Meliora can also be administered to adolescents.

Ovules - 500 mg

Film coated tablets - 20 mg

Tablets - 500 mg

Metformine is an oral antidiabetic which is not chemically or pharmacologically related to sulfonylurea derivatives. Metformine improves glucose tolerance in non-insulin-dependent diabetes mellitus by reducing basal and after-meal blood glucose levels. Metformine also reduces hepatic glucose production, intestinal glucose absorption and improves insulin sensitivity (increases peripheral glucose uptake).

Metformine is indicated in non-insulin-dependent diabetes mellitus when treatment by diet modification alone has not been effective and when the patient is overweight. Metformine may be used alone as initial treatment or in combination with a sulfonylurea derivative.

In insulin-dependent diabetes mellitus, Metformine may be used as adjunctive treatment in patients whose symptoms are difficult to manage.

Tablets - 850 mg

Metformine is an oral antidiabetic which is not chemically or pharmacologically related to sulfonylurea derivatives. Metformine improves glucose tolerance in non-insulin-dependent diabetes mellitus by reducing basal and after-meal blood glucose levels. Metformine also reduces hepatic glucose production, intestinal glucose absorption and improves insulin sensitivity (increases peripheral glucose uptake).

Metformine is indicated in non-insulin-dependent diabetes mellitus when treatment by diet modification alone has not been effective and when the patient is overweight. Metformine may be used alone as initial treatment or in combination with a sulfonylurea derivative.

In insulin-dependent diabetes mellitus, Metformine may be used as adjunctive treatment in patients whose symptoms are difficult to manage.

Film-coated tablets - 1000 mg

Metformine is an oral antidiabetic which is not chemically or pharmacologically related to sulfonylurea derivatives. Metformine improves glucose tolerance in non-insulin-dependent diabetes mellitus by reducing basal and after-meal blood glucose levels. Metformine also reduces hepatic glucose production, intestinal glucose absorption and improves insulin sensitivity (increases peripheral glucose uptake).

Metformine is indicated in non-insulin-dependent diabetes mellitus when treatment by diet modification alone has not been effective and when the patient is overweight. Metformine may be used alone as initial treatment or in combination with a sulfonylurea derivative.

In insulin-dependent diabetes mellitus, Metformine may be used as adjunctive treatment in patients whose symptoms are difficult to manage.

Tablets - 250 mg

Tablets - 100 mg

Film coated tablets - 50 mg

Metoprolol belongs to a group of drugs called cardioselective beta-blockers. It reduces cardiac contraction and decreases the heart rate.

Metoprolol is used in:

• management of arterial hypertension;
• angina pectoris;
• cardiac arrhythmias;
• myocardial infarction;
• adjuvant treatment in hyperthyroidism;
• migraine prophylaxis.

Tablets - 250 mg

Metronidazole, a synthetic derivative of nitroimidazole, acts against gram-positive and gram-negative anaerobic microorganisms (Bacteroides species, including the B.fragilis bacterial group, Clostridium species, Eubacterium species, Peptococcus species, Peptostreptococcus species and against protozoan (Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia). The mechanism of action of metronidazole is not yet clear. It is thought that metronidazole inhibits the synthesis of DNA. It has bactericidal action.

Metronidazol is used in:

• the treatment of infections caused by anaerobic microorganisms and infections from protozoa;
• prevention of postoperative infections caused by anaerobic bacteria, especially bacteroides and anaerobic streptococci species;
• the treatment of septicemia, bacteremia, peritonitis, brain abscess, necrotizing pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis and postoperative infections wounds when from them are isolated sensitive anaerobic pathogen microorganisms; urogenital trichomoniasis in females (trichomonial vaginitis) and in males; bacterial vaginosis (also known as non-specific vaginitis), or anaerobic vaginosis or Gardnerella vaginitis;
• acute ulcerative gingivitis; leg ulcers, infected by anaerobic microorganisms;
• acute dental infections (e.g. acute pericoronitis and acute apical infections);
• all forms of amoebiasis (intestinal and extraintestinal disease) and those of asymptomatic cyst holders;
• giardiasis;
• treatment of Helicobacter pylori, in combination with other medicines.

Solution for infusion - 0.5% - (5 g/1000 ml)

Metronidazole, a synthetic derivative of nitroimidazole, acts against gram-positive and gram-negative anaerobic microorganisms (Bacteroides species, including the B.fragilis bacterial group, Clostridium species, Eubacterium species, Peptococcus species, Peptostreptococcus species and against protozoan (Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia). The mechanism of action of metronidazole is not yet clear. It is thought that metronidazole inhibits the synthesis of DNA. It has bactericidal action.

Metronidazol is used in:

• the treatment of infections caused by anaerobic microorganisms and infections from protozoa;
• prevention of postoperative infections caused by anaerobic bacteria, especially bacteroides and anaerobic streptococci species;
• the treatment of septicemia, bacteremia, peritonitis, brain abscess, necrotizing pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis and postoperative infections wounds when from them are isolated sensitive anaerobic pathogen microorganisms; urogenital trichomoniasis in females (trichomonial vaginitis) and in males; bacterial vaginosis (also known as non-specific vaginitis), or anaerobic vaginosis or Gardnerella vaginitis;
• acute ulcerative gingivitis; leg ulcers, infected by anaerobic microorganisms;
• acute dental infections (e.g. acute pericoronitis and acute apical infections);
• all forms of amoebiasis (intestinal and extraintestinal disease) and those of asymptomatic cyst holders;
• giardiasis;
• treatment of Helicobacter pylori, in combination with other medicines.

Solution for infusion - 5 g/1000 ml - 100 ml

Metronidazole, a synthetic derivative of nitroimidazole, acts against gram-positive and gram-negative anaerobic microorganisms (Bacteroides species, including the B.fragilis bacterial group, Clostridium species, Eubacterium species, Peptococcus species, Peptostreptococcus species and against protozoan (Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia). The mechanism of action of metronidazole is not yet clear. It is thought that metronidazole inhibits the synthesis of DNA. It has bactericidal action.

Metronidazol is used in:

• the treatment of infections caused by anaerobic microorganisms and infections from protozoa;
• prevention of postoperative infections caused by anaerobic bacteria, especially bacteroides and anaerobic streptococci species;
• the treatment of septicemia, bacteremia, peritonitis, brain abscess, necrotizing pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis and postoperative infections wounds when from them are isolated sensitive anaerobic pathogen microorganisms; urogenital trichomoniasis in females (trichomonial vaginitis) and in males; bacterial vaginosis (also known as non-specific vaginitis), or anaerobic vaginosis or Gardnerella vaginitis;
• acute ulcerative gingivitis; leg ulcers, infected by anaerobic microorganisms;
• acute dental infections (e.g. acute pericoronitis and acute apical infections);
• all forms of amoebiasis (intestinal and extraintestinal disease) and those of asymptomatic cyst holders;
• giardiasis;
• treatment of Helicobacter pylori, in combination with other medicines.

Tablets - 4mg

Oral suspension - 125 mg/5 ml - 120 ml

Mezyl contains the active ingredient metronidazole. Metronidazole, a synthetic derivative of nitroimidazole, is active against several anaerobic gram-positive and gram-negative microorganisms (Bacteroides fragilis and other Bacteroides spp., Clostridium spp., Eubacterium spp., Peptococcus spp., and Peptostreptococcus spp.) and several protozoa (Trichomonas vaginalis, Entamoeba histolytica and Giardia lamblia). The mechanism of action of metronidazole is not entirely clear, but it is thought to inhibit DNA synthesis. Metronidazole has a bactericidal action.

It is indicated in:

• treatment of infections caused by anaerobic microorganisms, and protozoan infections;
• the prevention of post-operative infections due to anaerobic bacteria, particularly species of Bacteroides and anaerobic Streptococci;
• treatment of septicaemia, bacteraemia, peritonitis, brain abscesses, necrotizing pneumonia, osteomyelitis, puerperal sepsis, pelvic abscesses, pelvic cellulitis and post-operative wound infections from which pathogenic anaerobes have been isolated, urogenital trichomoniasis in females (trichomonal vaginitis) and in males; bacterial vaginosis (known as nonspecific vaginitis), anaerobic vaginosis or Gardnerella vaginitis;
• acute ulcerative gingivitis; anaerobically-infected leg ulcers or pressure sores;
• acute dental infections (e.g. acute pericoronitis and acute apical infections);
• all forms of amoebiasis (intestinal and extra-intestinal disease) and symptomless cyst passers;
• giardiasis;
• eradication of Helicobacter pylori, in combination with other drugs.

Tablets - 500 mg

Metronidazole, a synthetic derivative of nitroimidazole, acts against gram-positive and gram-negative anaerobic microorganisms (Bacteroides species, including the B.fragilis bacterial group, Clostridium species, Eubacterium species, Peptococcus species, Peptostreptococcus species and against protozoan (Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia). The mechanism of action of metronidazole is not yet clear. It is thought that metronidazole inhibits the synthesis of DNA. It has bactericidal action.

 Mezyl Forte is used in:

• the treatment of infections caused by anaerobic microorganisms and infections from protozoa;
• prevention of postoperative infections caused by anaerobic bacteria, especially bacteroides and anaerobic streptococci species;
• the treatment of septicemia, bacteremia, peritonitis, brain abscess, necrotizing pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis and postoperative infections wounds when from them are isolated sensitive anaerobic pathogen microorganisms; urogenital trichomoniasis in females (trichomonial vaginitis) and in males; bacterial vaginosis (also known as non-specific vaginitis), or anaerobic vaginosis or Gardnerella vaginitis;
• acute ulcerative gingivitis; leg ulcers, infected by anaerobic microorganisms;
• acute dental infections (e.g. acute pericoronitis and acute apical infections);
• all forms of amoebiasis (intestinal and extraintestinal disease) and those of asymptomatic cyst holders;
• giardiasis;
• treatment of Helicobacter pylori, in combination with other medicines.

Cream - ( 30 mg + 0.25 mg ) / g

Oral gel - 20 mg / g

Micotar oral gel contains the active substance miconazole, which is an antimycotic for use in the oral cavity.

Oral gel - 20 mg / g

Micotar oral gel contains the active substance miconazole, which is an antimycotic for use in the oral cavity.